Danshensu for Myocardial Ischemic Injury: Preclinical Evidence and Novel Methodology of Quality Assessment Tool

• Үндсэн зохиолчид: Xiao-yi Bao (Зохиогч), Qun Zheng (Зохиогч), Qiang Tong (Зохиогч), Peng-chong Zhu (Зохиогч), Zhuang Zhuang (Зохиогч), Guo-qing Zheng (Зохиогч), Yan Wang (Зохиогч)
• Формат: Ном
• Хэвлэсэн: Frontiers Media S.A., 2018-12-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

Background: Danshensu (DSS) possesses unique bioactivity on the cardiovascular system. However, there is a lack of systematical summary of DSS for acute myocardial ischemia injury and no quality assessment tool for the systematical review of cell experiments. Here, we aimed to assess the preclinical...